Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from DKSH Holding AG ( (CH:DKSH) ).
DKSH has announced the acquisition of Biomedic Science Material Joint Stock Company, a prominent distributor in Vietnam’s biotechnology and diagnostic market. This strategic move aims to enhance DKSH Technology’s presence in the life science and healthcare sectors across Vietnam, leveraging Biomedic’s established customer base and expertise. The acquisition is expected to provide growth opportunities for DKSH and deliver benefits to business partners and employees.
The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.
More about DKSH Holding AG
DKSH is a leading Market Expansion Services provider with a history of 160 years, operating in 36 markets with 28,060 specialists. The company offers services in Healthcare, Consumer Goods, Performance Materials, and Technology, generating net sales of CHF 11.1 billion in 2024. DKSH’s Business Unit Technology provides solutions for scientific and industrial applications, with net sales of CHF 549 million in 2024.
Average Trading Volume: 87,216
Technical Sentiment Signal: Sell
Current Market Cap: CHF3.7B
See more insights into DKSH stock on TipRanks’ Stock Analysis page.